ERBB2 and breast carcinoma: By integrating RNA and protein expression data from Reverse-Phase Protein Array Analysis (RPPA) in HER2+ breast cancer from the TCGA repository, we identified several gene expression metagenes that reflect the level of pathway activation according to the expression of proteins and/or phosphorylated-proteins relevant in cancer.